These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48. Importance of the pharmacological profile of thrombolytic agents in clinical practice. Alpert JS. Am J Cardiol; 1991 Dec 05; 68(16):3E-7E. PubMed ID: 1746449 [Abstract] [Full Text] [Related]
49. Cost and procedure implications of thrombolytic therapy for acute myocardial infarction. Steinberg EP, Topol EJ, Sakin JW, Kahane SN, Appel LJ, Powe NR, Anderson GF, Erickson JE, Guerci AD. J Am Coll Cardiol; 1988 Dec 05; 12(6 Suppl A):58A-68A. PubMed ID: 3057037 [Abstract] [Full Text] [Related]
50. Accelerated thrombolysis and reperfusion in a canine model of myocardial infarction by liposomal encapsulation of streptokinase. Nguyen PD, O'Rear EA, Johnson AE, Patterson E, Whitsett TL, Bhakta R. Circ Res; 1990 Mar 05; 66(3):875-8. PubMed ID: 2306811 [Abstract] [Full Text] [Related]
55. Newer agents for coronary thrombolysis. Perspectives from clinical studies. Di Minno G, Margaglione M, Cerbone AM, Papa R, Mattei A. Pharmacol Res; 1989 Mar 05; 21(2):153-61. PubMed ID: 2664750 [Abstract] [Full Text] [Related]
57. Aspect of thrombolytic therapy: a review. Ali MR, Salim Hossain M, Islam MA, Saiful Islam Arman M, Sarwar Raju G, Dasgupta P, Noshin TF. ScientificWorldJournal; 2014 Mar 05; 2014():586510. PubMed ID: 25574487 [Abstract] [Full Text] [Related]